Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Interest Coverage Ratio of 0.38 in Q1 2026, up 95.82% quarter-over-quarter from 8.97 in Q4 2025, and up 94.82% on a YoY basis from 0.19 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.38 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 94.82% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 6.48 (down 6.29% YoY), while the FY2025 annual figure was 7.98, down 61.46% from the prior year.
- Interest Coverage Ratio was 0.38 for Q1 2026 at Maravai Lifesciences Holdings, up from 8.97 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 62.83 in Q1 2022 to a low of 12.15 in Q3 2024.
- Historically, Interest Coverage Ratio has averaged 5.75 across 5 years, with a median of 1.32 in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 444.55% in 2022, then sank 911.03% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 10.73 in 2022, then plunged by 104.33% to 0.46 in 2023, then plunged by 620.98% to 3.35 in 2024, then sank by 167.95% to 8.97 in 2025, then surged by 95.82% to 0.38 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.38 (Q1 2026), 8.97 (Q4 2025), and 6.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Maravai Lifesciences Holdings | 737.25 Mn | 728.85 Mn | 33.70 Mn | -0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.38 |
| Dec 31, 2025 | -8.97 |
| Sep 30, 2025 | -6.00 |
| Jun 30, 2025 | -9.73 |
| Mar 31, 2025 | -7.25 |
| Dec 31, 2024 | -3.35 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.74 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.65 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 10.73 |
| Sep 30, 2022 | 37.28 |
| Jun 30, 2022 | 40.75 |
| Mar 31, 2022 | 62.83 |
| Dec 31, 2021 | 22.01 |
| Sep 30, 2021 | 20.22 |
| Jun 30, 2021 | 20.07 |